Top Markets
Coin of the day
Chandra Bhagat Pharma Limited Chandra Bhagat Pharma Limited

Chandra Bhagat Pharma Limited

CBPL
Rang in Aktien #35293
Chandra Bhagat Pharma Ltd. specializes in the distribution and... Chandra Bhagat Pharma Ltd. specializes in the distribution and commercialization of a diverse array of pharmaceutical, critical care, and general healthcare solutions. Their extensive product lineup encompasses various pharmaceutical formulations, notably intravenous (IV) and intramuscular (IM) injectable medications, alongside select tablet forms, serving both national and international clientele. Furthermore, the company actively promotes and markets active pharmaceutical ingredients (APIs). Their offerings are designed to address a spectrum of conditions, including rheumatoid and osteo-arthritis, osteoporosis, carpal tunnel syndrome, tendonitis, rotator cuff tears, muscular dystrophy, myasthenia gravis, and lupus erythematosus, among other health issues. Established in 1944 by Chandravadan C. Bhagat, the company's main operations are based in Mumbai, India.
Aktienkurs
$0.55069028
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$4.15M
Veränderung (1 Tag)
-4.95%
Veränderung (1 Jahr)
-12.17%
Land
IN
Handel Chandra Bhagat Pharma Limited (CBPL)

Kategorie

Dividendenrendite-Verlauf für Chandra Bhagat Pharma Limited (CBPL)
Dividendenrendite (TTM) von Chandra Bhagat Pharma Limited (Aktienkürzel: CBPL) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Chandra Bhagat Pharma Limited (CBPL) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber